Skip to main content

Marie A. Vodicka

ID:LEX-AR-QS87N8H5

/

Unclaimed

/

Organization: Hogan Lovells

FDA Denies 5-Year Exclusivity to “Stable Esters” and Confirms Structure-Based Approach to Exclusivity

Focus on Regulation · October 1, 2012

Biosimilars Marching Forward as Planned

Biosimilars Law Blog · June 29, 2012

Breaking decisions from the Supreme Court: Term in review

Biosimilars Law Blog · June 21, 2012

Making U.S. Biosimilars a Reality – Everyone Seeks Clarity and Direction from FDA

Biosimilars Law Blog · May 16, 2012

SCOTUS review of the Patient Protection and Affordable Care Act and “the biosimilar thing”

Biosimilars Law Blog · April 16, 2012